[go: up one dir, main page]

WO2006002841A3 - Methode d'analyse - Google Patents

Methode d'analyse Download PDF

Info

Publication number
WO2006002841A3
WO2006002841A3 PCT/EP2005/006866 EP2005006866W WO2006002841A3 WO 2006002841 A3 WO2006002841 A3 WO 2006002841A3 EP 2005006866 W EP2005006866 W EP 2005006866W WO 2006002841 A3 WO2006002841 A3 WO 2006002841A3
Authority
WO
WIPO (PCT)
Prior art keywords
mass
terminal
labelled peptide
internal standard
peptide internal
Prior art date
Application number
PCT/EP2005/006866
Other languages
English (en)
Other versions
WO2006002841A2 (fr
Inventor
Fredrik Nilsson
Original Assignee
Bioinvent Int Ab
Fredrik Nilsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent Int Ab, Fredrik Nilsson filed Critical Bioinvent Int Ab
Priority to EP05772836A priority Critical patent/EP1759213A2/fr
Priority to CA002611596A priority patent/CA2611596A1/fr
Priority to JP2007517213A priority patent/JP2008503738A/ja
Publication of WO2006002841A2 publication Critical patent/WO2006002841A2/fr
Publication of WO2006002841A3 publication Critical patent/WO2006002841A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne une méthode de mesure quantitative par spectrométrie de masse d'un peptide ou de peptides générés par une ou plusieurs protéines d'analysat par clivage enzymatique ou chimique. La méthode consiste à exposer ensemble l'échantillon à analyser et un ou plusieurs précurseurs de normes internes peptidiques marquées en masse à un clivage enzymatique ou chimique de façon à générer à partir dudit précurseur une ou plusieurs normes internes peptidiques marquées en masse. Le précurseur de normes internes peptidiques marquées en masse comprend une extension d'au moins un acide aminé N-terminal vers la terminaison N de la norme interne peptidique marquée en masse la plus N-terminale qui en est issue; et une extension d'au moins un acide aminé C-terminal vers la terminaison C de la norme interne peptidique marquée en masse la plus C-terminale qui en est issue.
PCT/EP2005/006866 2004-06-25 2005-06-22 Methode d'analyse WO2006002841A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05772836A EP1759213A2 (fr) 2004-06-25 2005-06-22 Methode d'analyse
CA002611596A CA2611596A1 (fr) 2004-06-25 2005-06-22 Methode d'analyse
JP2007517213A JP2008503738A (ja) 2004-06-25 2005-06-22 分析方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0414233A GB0414233D0 (en) 2004-06-25 2004-06-25 Analysis method
GB0414233.7 2004-06-25

Publications (2)

Publication Number Publication Date
WO2006002841A2 WO2006002841A2 (fr) 2006-01-12
WO2006002841A3 true WO2006002841A3 (fr) 2006-04-20

Family

ID=32800164

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/006866 WO2006002841A2 (fr) 2004-06-25 2005-06-22 Methode d'analyse

Country Status (6)

Country Link
EP (1) EP1759213A2 (fr)
JP (1) JP2008503738A (fr)
AU (1) AU2005259524A1 (fr)
CA (1) CA2611596A1 (fr)
GB (1) GB0414233D0 (fr)
WO (1) WO2006002841A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005004902T2 (de) * 2005-06-02 2008-10-16 Entelechon Gmbh Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung
SG173310A1 (en) * 2006-03-23 2011-08-29 Emelita De Guzman Breyer Apolipoprotein fingerprinting technique
JP4913587B2 (ja) 2006-12-28 2012-04-11 雪印メグミルク株式会社 ペプチドおよびタンパク質定量法
WO2008146100A1 (fr) * 2007-06-01 2008-12-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthode de quantification absolue de polypeptides
JP5999699B2 (ja) * 2012-11-16 2016-09-28 国立研究開発法人理化学研究所 タンパク質定量方法
CN106556651B (zh) * 2015-09-30 2019-06-07 深圳翰宇药业股份有限公司 检测丙氨酸、赖氨酸、谷氨酸和/或酪氨酸的方法
GB201521903D0 (en) * 2015-12-11 2016-01-27 Electrophoretics Ltd Isorbaric mass labels
EP3196646B1 (fr) * 2016-01-19 2019-12-18 Hexal AG Procédés de mappage de variants de protéines

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016861A2 (fr) * 2001-08-14 2003-02-27 President And Fellows Of Harvard College Quantification absolue de proteines et de formes modifiees de proteine par spectrometrie de masse multistade
WO2003046148A2 (fr) * 2001-11-29 2003-06-05 Thermo Finnigan Llc Quantification de polypeptide
US20040005633A1 (en) * 2001-03-22 2004-01-08 Joel Vandekerckhove Methods and apparatuses for gel-free qualitative and quantitative proteome analysis, and uses therefore
WO2005116660A2 (fr) * 2004-05-25 2005-12-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methode de mise au point et d'utilisation de normes de marqueurs de masse applicables a la proteomique quantitative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005633A1 (en) * 2001-03-22 2004-01-08 Joel Vandekerckhove Methods and apparatuses for gel-free qualitative and quantitative proteome analysis, and uses therefore
WO2003016861A2 (fr) * 2001-08-14 2003-02-27 President And Fellows Of Harvard College Quantification absolue de proteines et de formes modifiees de proteine par spectrometrie de masse multistade
WO2003046148A2 (fr) * 2001-11-29 2003-06-05 Thermo Finnigan Llc Quantification de polypeptide
WO2005116660A2 (fr) * 2004-05-25 2005-12-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methode de mise au point et d'utilisation de normes de marqueurs de masse applicables a la proteomique quantitative

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARNIDGE DAVID R ET AL: "Evaluation of a cleavable stable isotope labeled synthetic peptide for absolute protein quantification using LC-MS/MS", JOURNAL OF PROTEOME RESEARCH, vol. 3, no. 3, May 2004 (2004-05-01), pages 658 - 661, XP002360371, ISSN: 1535-3893 *
KRIJGSVELD J ET AL: "Quantitative proteomics by metabolic labeling with stable isotopes", DRUG DISCOVERY TODAY: TARGETS 2004 UNITED KINGDOM, vol. 3, no. 2 SUPPL.1, 2004, pages S11 - S15, XP002360372, ISSN: 1741-8372 *
LIU RUTAO ET AL: "Structural reorganization of the transferrin C-lobe and transferrin receptor upon complex formation: The C-lobe binds to the receptor helical domain.", BIOCHEMISTRY, vol. 42, no. 43, 4 November 2003 (2003-11-04), pages 12447 - 12454, XP002360384, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
JP2008503738A (ja) 2008-02-07
WO2006002841A2 (fr) 2006-01-12
GB0414233D0 (en) 2004-07-28
AU2005259524A1 (en) 2006-01-12
EP1759213A2 (fr) 2007-03-07
CA2611596A1 (fr) 2006-01-12

Similar Documents

Publication Publication Date Title
Julka et al. Quantification in proteomics through stable isotope coding: a review
Ahn et al. Accessing the reproducibility and specificity of pepsin and other aspartic proteases
CN101600959B (zh) 肽和蛋白的定量方法
Schrader et al. Historical perspective of peptidomics
Li et al. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures
Li et al. Peptides in the brain: mass spectrometry–based measurement approaches and challenges
US8871688B2 (en) Method for absolute quantification of polypeptides
DE602007011937D1 (de) Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
WO2004094460A3 (fr) Polypeptides lies aux peptides natriuretiques, procedes d'identification et d'utilisation de ces derniers
WO2004094459A3 (fr) Polypeptides lies a des peptides natriuretiques et leurs procedes d'identification et d'utilisation
WO2003074992A3 (fr) Proteines phosphorylees et utilisations associees
ATE460666T1 (de) Verfahren zur bestimmung der aminosäurensequenz von peptiden
WO2006130787A3 (fr) Procede simultane d'etalonnage de spectre de masse et d'identification de peptides dans une analyse proteomique
WO2002008767A3 (fr) Nouveaux procedes et trousses de sequençage de polypeptides
WO2008073146A3 (fr) Procédé et appareil pour induire le clivage par pyrolyse dans des peptides et des protéines
ATE444490T1 (de) Peptidfragmentation
WO2009061904A8 (fr) Analyse par spectrométrie de masse de l'activité du elf4e et du régulon elf4e
WO2006002841A3 (fr) Methode d'analyse
TW200420491A (en) Integrated microfluidic electro-spray chip system and the analysis method thereof
WO2005019831A3 (fr) Procedes pour la reduction de la complexite d'un echantillon au moyen d'anticorps a des sites antigeniques de petite dimension
Hauser et al. Online microwave D-cleavage LC-ESI-MS/MS of intact proteins: site-specific cleavages at aspartic acid residues and disulfide bonds
WO2013044265A3 (fr) Dosage mrm en multiplex pour évaluer un cancer
Pan et al. N-terminal labeling of peptides by trypsin-catalyzed ligation for quantitative proteomics.
AU2174002A (en) Method for analyzing proteins
WO2005116660A3 (fr) Methode de mise au point et d'utilisation de normes de marqueurs de masse applicables a la proteomique quantitative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005259524

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005772836

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007517213

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

ENP Entry into the national phase

Ref document number: 2005259524

Country of ref document: AU

Date of ref document: 20050622

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005259524

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005772836

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2611596

Country of ref document: CA

WWW Wipo information: withdrawn in national office

Ref document number: 2005772836

Country of ref document: EP